FDA Approved: CLOFARABINE — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved a supplemental application for Clofarabine (generic) by Mylan Institutional LLC under ANDA208860.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Clofarabine (generic) (Clofarabine)

Snippet

SUPPL AP for CLOFARABINE (CLOFARABINE)